Predicted 25-hydroxyvitamin D score and change in fasting plasma glucose in the Framingham offspring study

European Journal of Clinical Nutrition

Volumn 66, Issue 1, 2012, Pages 139-141

  Liu, E ^a   McKeown, N M ^b,c   Pittas, A G ^d   Meigs, J B ^e   Economos, C D ^c   Booth, S L ^b,c   Jacques, P F ^b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b TUFTS UNIVERSITY   (United States)

^c TUFTS UNIVERSITY   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

fasting plasma glucose; Framingham offspring cohort; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; GLUCOSE;

25 HYDROXYVITAMIN D SCORE; ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SCORING SYSTEM;

BLOOD GLUCOSE; FASTING; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VITAMIN D;

EID: 84855509029     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2011.181     Document Type: Article

References (19)

1. Alvarez JA, Ashraf AP, Hunter GR, Gower BA (2010). Serum 25-hydroxyvitamin D and parathyroid hormone are independent determinants of whole-body insulin sensitivity in women and may contribute to lower insulin sensitivity in African Americans. Am J Clin Nutr 92, 1344-1349.
2. Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS (2010). Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer 102, 1422-1427.
3. Ford ES, Ajani UA, McGuire LC, Liu S.2005). Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28, 1228-1230. (Pubitemid 40616645)
4. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ (2008). Baseline serum 25-hydroxy vitamin D is predictive of future glycaemic status and insulin resistance: The MRC Ely prospective study 1990 - 2000. Diabetes 57, 2619-2625.
5. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ et al (2006). Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.[see comment]. J Natl Cancer Inst 98, 451-459.
6. Jani R, Molina M, Matsuda M, Balas B, Chavez A, DeFronzo RA et al (2008). Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range. Diabetes Care 31, 311-315. (Pubitemid 351213342)
7. Lee S, Clark SA, Gill RK, Christakos S.1994). 1,25-dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 134, 1602-1610.
8. Liu E, Meigs JB, Pittas AG, Economos CD, McKeown NM, Booth SLet al (2010). Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr 91, 1627-1633.
9. Maestro B, Campion J, Davila N, Calle C.2000). Stimulation by 1,25- dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47, 383-391.
10. Mattila C, Knekt P, Mannisto S, Rissanen H, Laaksonen MA, Montonen J et al (2007). Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30, 2569-2570. (Pubitemid 47547796)
11. Nagpal J, Pande JN, Bhartia A.2009). A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26, 19-27.
12. Need AG, O'Loughlin PD, Horowitz M, Nordin BE (2005). Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol 62, 738-741. (Pubitemid 40825945)
13. Norman AW (2006). Minireview: vitamin D receptor: New assignments for an already busy receptor. Endocrinology 147, 5542-5548. (Pubitemid 44833469)
14. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE et al (2006). Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29, 650-656. (Pubitemid 44115368)
15. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B.2007a). The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30, 980-986. (Pubitemid 46556596)
16. Pittas AG, Lau J, Hu FB, Dawson-Hughes B.2007b). The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 2017-2029. (Pubitemid 46997093)
17. Scragg R, Sowers M, Bell C.2004). Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27, 2813-2818. (Pubitemid 39565042)
18. Soares MJ, Ping-Delfos WC, Sherriff JL, Nezhad DH, Cummings NK, Zhao Y (2011). Vitamin D and parathyroid hormone in insulin resistance of abdominal obesity: Cause or effect? Eur J Clin Nutr; e-pub ahead of print 29 June 2011; doi:10.1038/ejcn.2011.111.
19. Von Hurst PR, Stonehouse W, Coad J.2010). Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 103, 549-555.